BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis [1]

Cell Death and Differentiation

Volumn 10, Issue 3, 2003, Pages 383-385

  Romano, M F ^a   Festa, M ^b   Pagliuca, G ^a,b   Lerose, R ^b   Bisogni, R ^a   Chiurazzi, F ^a   Storti, G ^c   Volpe, S ^c   Venuta, S ^d   Turco, M C ^c   Leone, A ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c S G MOSCATI HOSPITAL   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BCL 2 ASSOCIATED ATHANOGENE 3 PROTEIN; CASPASE 3; CHAPERONE; CYTOCHROME C; FLUDARABINE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; B CELL LEUKEMIA; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LETTER; LEUKEMOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; LEUKEMIA, B-CELL; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 0037621432     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401167     Document Type: Letter

References (23)

1. Reed J (1998) Clin. Immunol. Newslett. 17: 125-140.
2. Caligaris-Cappio F (2000) Rev Clin Exp Hematol. 4:5-21.
3. Thomas A et al. (1996) Oncogene 12: 1055-1056
4. Kitada S et al. (1998) Blood 91: 3379-3389.
5. Kitada S et al. (2000) Blood 96:393-397.
6. Byrd JC et al. (2002) Blood 99:1038-1043.
7. Romano MF et al. (1998) Blood 92: 990-995.
8. Takayama S et al. (2001) Nature Cell Biol. 3: 237-241.
9. Takayama S et al. (1999) J Biol Chem. 274:781-786.
10. Lee J-H et al. (1999) Oncogene 18: 6183-6190.
11. Doong H et al. (2000) Oncogene 19: 4385-4395.
12. Antoku K et al. (2001) Biochem Biophys Res Comm. 286: 1003-1010.
13. Kluck RM et al. (1997) EMBO J 16: 4639-4649.
14. Nicholson DW et al. (1995) Nature 376: 37-39.
15. Romano MF et al. (1999) Blood 12: 4060-4066.
16. Romano MF et al. (2000) Gene Ther 7: 1234-1237.
17. Nicoletti I et al. (1991) J Immunol Methods 139:271-278.
18. Jaattela M (1999) Ann Med. 31: 261-265
19. Beere HM et al. (2001) Trends Cell Biol 11: 6-10.
20. Cory S. (1995) Annu Rev Immunol. 13: 513-543.
21. Lomo J et al. (1996) Cancer Res 56: 40-43.
22. Harris MH et al. (2000) Cell Death Differ 7: 1182-1191.
23. Bonzon C et al. (2002) Cell Death Differ 9: 780-782.